Postgraduate Medical Journal 1990-01-01

Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.

M Ravic, A Johnston, P Turner

Index: Postgrad. Med. J. 66 Suppl 4 , S30-4, (1990)

Full Text: HTML

Abstract

A series of studies in human subjects of potential interactions of lornoxicam with some other drugs is reviewed. No evidence of kinetic interaction was found with the antacids Maalox or Solugastrol, nor was there evidence of influence on antipyrine clearance. Lornoxicam reduced warfarin clearance and enhanced its hypoprothrombinaemic effect. It did not influence glibenclamide kinetics, but plasma insulin concentrations were significantly higher and plasma glucose concentrations significantly lower when lornoxicam and glibenclamide were co-administered. Lornoxicam produced a modest reduction in digoxin clearance, but no other clear evidence of interaction was seen. Lornoxicam significantly antagonized the diuretic and natriuretic actions of frusemide.


Related Compounds

Related Articles:

Intra-articular levobupivacaine, lornoxicam and morphine analgesia after knee arthroscopy: a randomized, controlled trial.

2012-01-01

[Acta Orthop. Traumatol. Turc. 46(6) , 411-5, (2012)]

Characterization of two polymorphs of lornoxicam.

2013-01-01

[J. Pharm. Pharmacol. 65(1) , 44-52, (2013)]

Investigation on the micelle-sensitized Ce(IV)-lornoxicam-Rh B chemiluminescence system and its application.

2012-01-01

[J. Fluoresc. 22(1) , 529-35, (2012)]

Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration.

2011-01-01

[Drug Deliv. 18(7) , 536-44, (2011)]

Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam.

1990-01-01

[Postgrad. Med. J. 66 Suppl 4 , S18-21, (1990)]

More Articles...